Showing results (1-10 of 84) with videos related to
Sort By:
Pageof 9
Recent Patents on Inflammation & Allergy Drug Discovery|September 3, 2010
TNF-alpha antagonism in severe asthma?Dhananjay Desai, Christopher BrightlingAdvances in Clinical Chemistry|August 9, 2012
Cytokines and cytokine-specific therapy in asthmaDhananjay Desai, Christopher BrightlingCurrent Opinion in Pulmonary Medicine|November 4, 2010
Can inhaled corticosteroids prevent asthma exacerbations?Dhananjay Desai, Salman Siddiqui, Christopher BrightlingExpert Review of Respiratory Medicine|April 9, 2016
Mepolizumab for the reduction of exacerbations in severe eosinophilic asthmaRichard Russell, Christopher BrightlingChest|February 9, 2012
OX40/OX40 ligand interactions in T-cell regulation and asthmaDavinder Kaur, Christopher BrightlingThe European Respiratory Journal|May 11, 2019
Airway inflammation in COPD: progress to precision medicineChristopher Brightling, Neil GreeningIndian Journal of Microbiology|July 14, 2020
A Recent Overview of Microbes and Microbiome PreservationOm Prakash, Yogesh Nimonkar, Dhananjay DesaiThe World Allergy Organization Journal|November 16, 2013
Section 3. A discussion of flexible dosing and patient-centered therapy: highlights of the asthma summit 2009: beyond the guidelinesG Walter Canonica, Christopher BrightlingClinical Science (London, England : 1979)|July 2, 2017
Pathogenesis of asthma: implications for precision medicineRichard J Russell, Christopher BrightlingExpert Opinion on Investigational Drugs|January 25, 2018
Fevipiprant in the treatment of asthmaChristobelle White, Adam Wright, Christopher BrightlingPageof 9